世界の次世代がん診断市場は2021年に約79億8,000万米ドルと評価され、2022年から2029年の予測期間にわたって12.38％を超える健全な成長率で成長すると予想されています。がん診断は、さまざまなタンパク質、バイオマーカー、症状を調べて、患者の悪性腫瘍の存在を特定する技術です。がんを特定する方法には、特定のテクノロジーと診断ツールが広範囲に使用されます。次世代がん診断市場は、がんの発生率の増加、クラスターチップ技術の開発、がん管理におけるCTCの潜在的な応用などの要因により拡大しています。
国際がん研究機関（IARC）の推計によると、世界的にがんの有病率が上昇しており、市場の成長を促進している。がんによる世界的な負担の増加は、2021年の190万件から2040年までに新たに2,750万件に増加すると推定されています。さらに、製品および技術開発のためのFDA認可の取得、予防医学およびコンパニオン診断の需要の高まり、がん治療薬の研究開発活動の高まりが、市場に有利な成長をもたらしています。例えば、2022年8月、次世代シーケンサーに基づくがん診断薬の検証および規制審査プロセスを強化するパイロットプロジェクトを用いて、米国食品医薬品局との官民パートナーシップで医療機器規制科学の発展に取り組んでいるMedical Device Innovation Consortium（MDIC）社、体細胞参照サンプル（SRS）イニシアチブ（NGS）の次のフェーズを開始したと発表しました。しかし、新規検査の実施には高価なラボのセットアップが必要であるため、市場の成長を妨げる可能性があります。
次世代がん診断の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、ブランド製品の優位性と疾病の増加により、売上高で市場を支配しています。一方、アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想されています。これは、老年人口および対象人口の増加、製品開発のための共同研究の増加、主要企業の地域的拡大、政府および非営利団体の市場への積極的な参加などの要因によります。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Next Generation Cancer Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Next Generation Cancer Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Next Generation Cancer Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Next Generation Cancer Diagnostics Market, by Cancer Type, 2019-2029 (USD Billion)
1.2.5. Next Generation Cancer Diagnostics Market, by Function, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Next Generation Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Next Generation Cancer Diagnostics Market Dynamics
3.1. Next Generation Cancer Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Cancer
3.1.1.2. Development of cluster chip technology and potential applications of CTC in cancer management
3.1.2. Market Challenges
3.1.2.1. Requirement of expensive laboratory set-up for implementation of novel tests
3.1.3. Market Opportunities
3.1.3.1. Rising demand for preventive medicine & companion diagnostics
3.1.3.2. Rising cancer medicine research and development activities
Chapter 4. Global Next Generation Cancer Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Next Generation Cancer Diagnostics Market, by Technology
6.1. Market Snapshot
6.2. Global Next Generation Cancer Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Next-Generation Sequencing
6.4.2. qPCR & Multiplexing
6.4.3. Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
6.4.4. Protein Microarrays
6.4.5. DNA Microarrays
Chapter 7. Global Next Generation Cancer Diagnostics Market, by Application
7.1. Market Snapshot
7.2. Global Next Generation Cancer Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Biomarker Development
7.4.2. CTC Analysis
7.4.3. Proteomic Analysis
7.4.4. Epigenetic Analysis
7.4.5. Genetic Analysis
Chapter 8. Global Next Generation Cancer Diagnostics Market, by Cancer Type
8.1. Market Snapshot
8.2. Global Next Generation Cancer Diagnostics Market by Cancer Type, Performance - Potential Analysis
8.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
8.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
8.4.1. Lung Cancer
8.4.2. Breast Cancer
8.4.3. Colorectal Cancer
8.4.4. Cervical Cancer
8.4.5. Others
Chapter 9. Global Next Generation Cancer Diagnostics Market, by Function
9.1. Market Snapshot
9.2. Global Next Generation Cancer Diagnostics Market by Function, Performance - Potential Analysis
9.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Function 2019-2029 (USD Billion)
9.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
9.4.1. Therapeutic Monitoring
9.4.2. Companion Diagnostics
9.4.3. Prognostics
9.4.4. Cancer Screening
9.4.5. Risk Analysis
Chapter 10. Global Next Generation Cancer Diagnostics Market, Regional Analysis
10.1. Next Generation Cancer Diagnostics Market, Regional Market Snapshot
10.2. North America Next Generation Cancer Diagnostics Market
10.2.1. U.S. Next Generation Cancer Diagnostics Market
10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.2. Application breakdown estimates & forecasts, 2019-2029
10.2.1.3. Cancer Type breakdown estimates & forecasts, 2019-2029
10.2.1.4. Function breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Next Generation Cancer Diagnostics Market
10.3. Europe Next Generation Cancer Diagnostics Market Snapshot
10.3.1. U.K. Next Generation Cancer Diagnostics Market
10.3.2. Germany Next Generation Cancer Diagnostics Market
10.3.3. France Next Generation Cancer Diagnostics Market
10.3.4. Spain Next Generation Cancer Diagnostics Market
10.3.5. Italy Next Generation Cancer Diagnostics Market
10.3.6. Rest of Europe Next Generation Cancer Diagnostics Market
10.4. Asia-Pacific Next Generation Cancer Diagnostics Market Snapshot
10.4.1. China Next Generation Cancer Diagnostics Market
10.4.2. India Next Generation Cancer Diagnostics Market
10.4.3. Japan Next Generation Cancer Diagnostics Market
10.4.4. Australia Next Generation Cancer Diagnostics Market
10.4.5. South Korea Next Generation Cancer Diagnostics Market
10.4.6. Rest of Asia Pacific Next Generation Cancer Diagnostics Market
10.5. Latin America Next Generation Cancer Diagnostics Market Snapshot
10.5.1. Brazil Next Generation Cancer Diagnostics Market
10.5.2. Mexico Next Generation Cancer Diagnostics Market
10.5.3. Rest of Latin America Next Generation Cancer Diagnostics Market
10.6. Rest of The World Next Generation Cancer Diagnostics Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Janssen Global Services, LLC
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Novartis AG
11.2.3. F. Hoffmann-La Roche Ltd
11.2.4. Koninklijke Philips N.V.
11.2.5. Abbott Laboratories
11.2.6. GE Healthcare
11.2.7. Thermo Fisher Scientific, Inc
11.2.8. Agilent Technologies (Dako) Inc.
11.2.9. Illumina, Inc.
11.2.10. Opko Health, Inc
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
List of Tables
TABLE 1. Global Next Generation Cancer Diagnostics Market, report scope
TABLE 2. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 4. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
TABLE 6. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Function 2019-2029 (USD Billion)
TABLE 7. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Next Generation Cancer Diagnostics Market
TABLE 72. List of primary sources, used in the study of global Next Generation Cancer Diagnostics Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Next Generation Cancer Diagnostics Market, research methodology
FIG 2. Global Next Generation Cancer Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Next Generation Cancer Diagnostics Market, key trends 2021
FIG 5. Global Next Generation Cancer Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Next Generation Cancer Diagnostics Market, porters 5 force model
FIG 7. Global Next Generation Cancer Diagnostics Market, pest analysis
FIG 8. Global Next Generation Cancer Diagnostics Market, value chain analysis
FIG 9. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Next Generation Cancer Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Next Generation Cancer Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
